Trastuzumab Completed Phase 3 Trials for Metastatic Brain Tumors Treatment

Indications	Status	Purpose	Phase
DBCOND0058867 (Metastatic Brain Tumors)	Completed	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT00820222	Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer	Trastuzumab (DB00072) Lapatinib (DB01259) Capecitabine (DB01101)